Boehringer Ingelheim announces the start of the THULITE Phase II clinical study. It will investigate the efficacy, safety and tolerability of BI 1815368 as a potential oral treatment to improve vision ...

A groundbreaking study from Flinders University reveals that it's not just making eye contact that matters, but precisely when and how you do it. By studying interactions between humans and virtual ...

The global Retinal Vein Occlusion (RVO) treatment market was valued at approximately USD 2.65 billion in 2023 and is projected to exhibit a compound annual growth rate (CAGR) of 6.92% over the ...

If you have daily living and/or mobility needs due to a sight condition or poor vision, you may be able to claim benefits.

Sanofi SNY has announced that the FDA has granted a fast-track designation to its one-time intravitreal gene therapy, ...

CMS is brokering outcomes-based agreements on behalf of Medicaid programs. Thirty-three states, along with Washington, D.C., ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

Kadi Patta, or curry leaves, are more than just flavour enhancers. They are packed with nutrients. These leaves are good for ...

Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Canadian leader in artificial intelligence (AI) for the ...

A large, prospective study implicates high levels of interleukin 6 with severity of diabetic retinopathy and shows it may be ...

Sanofi has been granted a speedy review from the FDA for a gene therapy for geographic atrophy (GA), a complication of age-related macular degeneration (AMD), as it prepares to test it in a clinical ...